ZooMAb antibodies represent an entirely new generation of recombinant monoclonal antibodies.Each ZooMAb antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Only top-performing clones are released for use by researchers. Each antibody is validated for high specificity and affinity across multiple applications, including its most commonly used application. ZooMAb antibodies are reliably available and ready to ship when you need them.Learn more about ZooMAb here.
Synonyms: HSP 86; HSP86; Heat shock 86 kDa; Heat shock protein HSP 90-alpha; LAP-2; LPS-associated protein 2; Lipopolysaccharide-associated protein 2; Renal carcinoma antigen NY-REN-38
Storage: 2-8C
Application: Western Blotting Analysis: A 1:1,000 dilution from a representative lot detected HSP90 alpha in lysates from NIH3T3 cells, human testis, and rat brain tissue.Affinity Binding Assay: A representative lot of this antibody bound human recombinant HSP90 alpha with a KD of 2.9 x 10-8 in an affinity binding assay.Immunohistochemistry (Paraffin) Analysis: A 1:100 dilution from a representative lot detected HSP90 alpha in human testis tissue sections.Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user
Legal Information: ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany